These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19916255)

  • 1. Special anniversary volume -- issue 4: replacement -- focus on the development of therapeutics. Preface.
    Balls M
    Altern Lab Anim; 2009 Sep; 37(4):353-4. PubMed ID: 19916255
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there an alternative?
    Farrant A
    Nurs Stand; 2003 Jul 2-8; 17(42):18-9. PubMed ID: 12874922
    [No Abstract]   [Full Text] [Related]  

  • 3. Special anniversary volume - issue 6: replacement - focus on the testing of chemicals and products. Preface.
    Balls M
    Altern Lab Anim; 2009 Dec; 37(6):593-4. PubMed ID: 20301829
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of alternative tests in the European Union.
    Balls M
    Curr Probl Dermatol; 1995; 23():265-74. PubMed ID: 9035921
    [No Abstract]   [Full Text] [Related]  

  • 5. The EU bans cosmetics testing on animals.
    Kuehn BM
    J Am Vet Med Assoc; 2003 Mar; 222(5):559. PubMed ID: 12619826
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modern drug development by molecular- and cell-biological methods].
    Döhmer J
    ALTEX; 2001; 18(1):9-12. PubMed ID: 11248843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccine (part 2).
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2006 Nov; 2006(1):73-88. PubMed ID: 17270133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosimilar medicines--new challenges for a new class of medicine.
    Fox A
    J Biopharm Stat; 2010 Jan; 20(1):3-9. PubMed ID: 20077245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 21st century drug development: advances, opportunities and challenges.
    Bhogal N
    Altern Lab Anim; 2009 Sep; 37(4):335-9. PubMed ID: 19807207
    [No Abstract]   [Full Text] [Related]  

  • 10. New uses for old drugs.
    Chong CR; Sullivan DJ
    Nature; 2007 Aug; 448(7154):645-6. PubMed ID: 17687303
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimising the design of preliminary toxicity studies for pharmaceutical safety testing in the dog.
    Smith D; Combes R; Depelchin O; Jacobsen SD; Hack R; Luft J; Lammens L; von Landenberg F; Phillips B; Pfister R; Rabemampianina Y; Sparrow S; Stark C; Stephan-Gueldner M
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):95-101. PubMed ID: 15698532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing alternatives to systemic toxicity testing approaches.
    von Aulock S
    ALTEX; 2012; 29(1):1. PubMed ID: 22408846
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated assessment of preclinical data: shifting high attrition rates to earlier phase drug development.
    Korstanje C
    Curr Opin Investig Drugs; 2003 May; 4(5):519-21. PubMed ID: 12833643
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of drug safety testing: expanding the view and narrowing the focus.
    Stevens JL; Baker TK
    Drug Discov Today; 2009 Feb; 14(3-4):162-7. PubMed ID: 19100337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Animal toxicology studies necessary for clinical research and the registry of drugs for human use: conclusions of the International Conference of Harmonization (and II)].
    Tristán C; Galende I; Rubio Terrés C; Duque I
    Med Clin (Barc); 1994 May; 102(20):791-6. PubMed ID: 7913735
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward using in vitro toxicology in the drug approval process.
    Ratner M
    Biotechnology (N Y); 1990 Dec; 8(12):1248-9. PubMed ID: 1366957
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 18. New screening tools for lead compound identification.
    Sawyer TK
    Nat Chem Biol; 2005 Aug; 1(3):125. PubMed ID: 16408012
    [No Abstract]   [Full Text] [Related]  

  • 19. Preface to the special issue "Novel pharmaconeurogenetic approaches arising from progress in translational genetics".
    Renger JJ; Kern JT
    J Neurogenet; 2011 Dec; 25(4):117-9. PubMed ID: 22074379
    [No Abstract]   [Full Text] [Related]  

  • 20. Unfinished business: target-based drug discovery.
    Brown D
    Drug Discov Today; 2007 Dec; 12(23-24):1007-12. PubMed ID: 18061878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.